To determine the genomic profile of Triple Negative Breast Cancer patient-derived xenografts (PDX cohort)
Specific BRCA and immune configurations determine optimal response to platinum-based chemotherapy in triple negative breast and ovarian carcinomas (PDX_WGS)
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001008535 | Illumina NovaSeq 6000 | 36 |
Publications | Citations |
---|---|
Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas.
Sci Transl Med 14: 2022 eabn1926 |
18 |